By: Dyana Williams, RCM Client Engagement Manager As we continue to optimize our clients’ billing practices, it is crucial to ensure they have a clear understanding of the use of the TC (Technical Component) modifier, especially in situations where a pathology group...
By: Dyana Williams, Client Engagement Manager Understanding and addressing claim denial reasons is crucial for the financial stability of medical and pathology laboratories. As part of a recent case study, our RCM Solutions Team delved into the denial patterns of two...
Last year, we notified drug testing providers CMS was reviewing definitive and presumptive drug screening claims for errors and missing documentation as part of its Targeted Probe and Educate (TPE) program. Results for the WPS Region were published last week, showing...
Building a laboratory within a gastroenterology (GI)practice can be a strategic move to boost control over your samples and improve your standing with private payers, providing physicians with opportunities for increased efficiency and revenue. In this guide,...
By: Dyana Williams, Client Engagement, Lighthouse RCM Solutions The following is a case study of a Gastrointestinal (GI) panel billing issue we helped a client navigate. The blog takes a light-hearted approach and unpacks the problem in the format of classic...
By: Dyana Williams, Client Engagement Manager, Lighthouse RCM Solutions Presumptive drug testing screens for drug presence, while definitive testing identifies specific drugs and concentrations. Both aid in patient care and treatment decisions. In the world of...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy